AC Immune Ltd (ACIU) — Capital Reinvestment Ratio
AC Immune Ltd (ACIU) has a Capital Reinvestment Ratio of 0.02x as of December 2024, meaning it reinvests 0% of its operating cash flow ($5.93 Million) in capital expenditures ($90.00K). See ACIU net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AC Immune Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks AC Immune Ltd's Capital Reinvestment Ratio across 3 annual periods. Check AC Immune Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for AC Immune Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for AC Immune Ltd from 2015 to 2024. For live market cap and broader valuation context, see AC Immune Ltd (ACIU) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $65.84 Million | $576.00K | ▼ -74.4% |
| 2019 | 0.03x | $55.22 Million | $1.89 Million | ▲ +516.7% |
| 2015 | 0.01x | $44.08 Million | $244.00K | — |